BCMA bispecific antibody therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BCMA bispecific antibody therapy, covering 2026-01-29 to 2026-01-29. Get the full timeline:
Most recent: Clinical Trial Update: BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM) [Phase 2]